RPS6KB1 and hypertriglyceridemia: As described by Uno et al. (2015), elevated liver amino acids activate mTORC1/S6K signalling, modulating lipid metabolism through a neuronal pathway that leads to hypertriglyceridemia via the downregulation of adipose lipoprotein lipase.